15th Annual Cardiovascular Disease Update: TRACK THREE

Controversies in Structural Heart Disease

[Non-CME eligible education program]

Cardiovascular disease is the leading cause of death in the United States for both men and women. Treatment approaches are helping prolong life with improved quality in many patients with advanced heart disease. This symposium will provide an in-depth review of current advances in the care of complex patients with cardiovascular disease. Practitioners should be able to incorporate many of the tips and tools from this case-based program into their daily practice.

DEBATE Aortic Valve Stenosis: Aspects to Consider When Treating Aortic Stenosis in the Low Risk "Young" Patient - Surgery is Better Video

DEBATE Aortic Valve Stenosis: Aspects to Consider When Treating Aortic Stenosis in the Low Risk "Young" Patient - Surgery is Better

DEBATE Aortic Valve Stenosis: Aspects to consider when treating aortic stenosis in the low risk "young" patient. Yakov Elgudin, MD, explains why surgery is better.
Yakov Elgudin, MD, PhD

Yakov Elgudin, MD, PhD

Chief, Division of Cardiothoracic Surgery, Louis Stokes Cleveland VA Medical Center
Assistant Professor, Case Western Reserve University School of Medicine
DEBATE Aortic Valve Stenosis: Aspects to Consider When Treating Aortic Stenosis in the Low Risk "Young" Patient - TAVI is Better Video

DEBATE Aortic Valve Stenosis: Aspects to Consider When Treating Aortic Stenosis in the Low Risk "Young" Patient - TAVI is Better

DEBATE Aortic Valve Stenosis: Aspects to consider when treating aortic stenosis in the low risk "young" patient. Toby Rogers, MD, PhD, explains why TAVI is better.
DEBATE Mitral Regurgitation: What is the Ideal Therapeutic Option for my Patient With Mitral Regurgitation - Surgical Options Video

DEBATE Mitral Regurgitation: What is the Ideal Therapeutic Option for my Patient With Mitral Regurgitation - Surgical Options

DEBATE Mitral Regurgitation: What is the ideal therapeutic option for my patient with mitral regurgitation - Yasir Abu-Omar, MD, DPhil, discusses the surgical options.
Yasir Abu-Omar, MD, FRCS, Dphil

Yasir Abu-Omar, MD, FRCS, Dphil

Cardiac Surgeon
Director, CT Transplantation, University Hospitals Harrington Heart & Vascular Institute
DEBATE Mitral Regurgitation: What is the Ideal Therapeutic Option for my Patient With Mitral Regurgitation - Percutaneous Options Video

DEBATE Mitral Regurgitation: What is the Ideal Therapeutic Option for my Patient With Mitral Regurgitation - Percutaneous Options

DEBATE Mitral Regurgitation: What is the ideal therapeutic option for my patient with mitral regurgitation - Anene Ukaigwe, MD, discusses the percutaneous options.
Anene Ukaigwe, MD

Anene Ukaigwe, MD

Interventional Cardiologist, University Hospitals Harrington Heart & Vascular Institute
Optimizing Percutaneous LAAO Procedure Video

Optimizing Percutaneous LAAO Procedure

Steven Filby, MD, gives a case presentation on optimizing percutaneous LAAO procedure.
Steven Filby, MD

Steven Filby, MD

Director, Cardiac Catheterization Laboratory, University Hospitals Harrington Heart & Vascular Institute
Associate Professor, Case Western Reserve University School of Medicine
Surgical Options for LAAO Video

Surgical Options for LAAO

Gregory Rushing, MD, discusses the surgical options for LAAO.
Gregory Rushing, MD

Gregory Rushing, MD

Director, Cardiac Surgery, University Hospitals Parma Medical Center
Clinical Instructor, Case Western Reserve University School of Medicine

Learn More from the 15th Annual Cardiovascular Disease Update:

TRACK ONE

TRACK TWO

TRACK FOUR

TRACK FIVE